SPOTLIGHT -
The FDA has approved Visudyne (verteporfinfor injection) therapy for the treatment of predominantly classic subfovealchoroidal neovascularization (CNV) caused by pathologic myopia and presumedocular histoplasmosis.
Mental health and ophthalmology
Claris Bio's journey toward treating neurotrophic keratitis
Connecticut ophthalmologist sentenced to prison for health care fraud scheme
(EyePod) From idea to impact: Navigating ophthalmic innovation
Prevent Blindness kicks off ‘It Started With an Eye Exam’
ARVO 2024: Abnormal subendothelial matrix exacerbates choroidal endothelial cell death in early AMD